bioMérieux South Africa

bioMérieux South Africa A world leader in the field of in vitro diagnostics for 60 years.

In emergency situations, every minute matters.Having rapid access to reliable information can make all the difference in...
19/06/2026

In emergency situations, every minute matters.
Having rapid access to reliable information can make all the difference in patient care and healthcare management.

Today, laboratories and medical teams need solutions that combine speed, ease of use, and service continuity, while helping control costs and operational constraints.

At bioMérieux, we support healthcare professionals with tools designed to meet real-world challenges: helping guide clinical decisions, streamline workflows, and contribute to better patient care, even in the most demanding environments.

🔗 Discover more here:https://www.biomerieux.com/content/dam/biomerieux-com/03----our-offer/clinical/in-hospital--in-lab/products/vidas-range/documents/vidas-emergency-panel-brochure.pdf

17/06/2026

🔬 Diagnostics in Action is underway!
This June, bioMérieux is launching a new webinar series designed for healthcare professionals across Africa. Through expert-led discussions, real-world clinical insights, and innovative diagnostic solutions, Diagnostics in Action aims to address some of the most pressing challenges in patient care.

🩸 The inaugural session focused on a critical topic: Bloodstream Infections and Sepsis Management, highlighting the clinical impact of the BIOFIRE® BCID2 Panel. A subject at the heart of rapid and effective diagnostic stewardship, explored by a distinguished panel of experts:

👩‍⚕️ Pr Thabet Lamia – Microbiology Professor, Vice-President of the Tunisian Society of Infectious Diseases (STPI) and Head of Lab, Trauma and Major Burns Center of Tunis (CTGB), Tunisia

👩‍⚕️ Pr Djennane Fazia – Microbiology Professor at Pharmacy Faculty of Algiers and Head of Microbiology Lab at Mother – Child at University Hospital Beni Messous d'Alger, Algeria

👨‍⚕️ Pr Mokhtar Ahmed – Director of Surgical and Trauma Intensive Care Unit at Cairo University and Director of critical care liver transplant unit at Airforce Specialized Hospital, Egypt.

Missed the live session? ▶️ The replay is now available.

Effective management of Acute Coronary Syndromes (ACS) depends on rapid diagnosis and evidence-based clinical decisions....
17/06/2026

Effective management of Acute Coronary Syndromes (ACS) depends on rapid diagnosis and evidence-based clinical decisions. The 2020 ESC guidelines provide a comprehensive framework to support optimized patient care across all ACS presentations.

They emphasize the importance of early assessment using high-sensitivity troponins and risk stratification tools such as the GRACE score, while guiding clinicians toward the most appropriate therapeutic strategy - whether invasive management or medical treatment - to improve patient outcomes and reduce mortality.

Sepsis, a rapidly progressing life-threatening emergency. In hospital settings, sepsis often arises as a progression of ...
15/06/2026

Sepsis, a rapidly progressing life-threatening emergency.

In hospital settings, sepsis often arises as a progression of healthcare-associated infections, within a context marked by increasing antimicrobial resistance. This interplay complicates patient management, with evolving microbiological profiles and sometimes limited therapeutic options. The challenge lies in early identification of pathogens, rapid risk stratification, and the initiation of appropriate antibiotic therapy, ideally guided by rapid diagnostic tools and relevant biomarkers, in order to optimize patient outcomes and reduce morbidity and mortality.

Cardiac troponins (cTnI and cTnT) are the reference biomarkers for the diagnosis of Acute Coronary Syndromes (ACS). Rele...
11/06/2026

Cardiac troponins (cTnI and cTnT) are the reference biomarkers for the diagnosis of Acute Coronary Syndromes (ACS). Released into the bloodstream shortly after myocardial injury, they provide a highly specific indication of cardiac damage.

Their measurement plays a key role in confirming myocardial infarction, including in patients with non-specific or inconclusive ECG findings. The introduction of high-sensitivity troponin assays has significantly improved the early detection and management of ACS.

Acute Coronary Syndromes (ACS) are among the most critical cardiovascular emergencies, encompassing conditions such as u...
09/06/2026

Acute Coronary Syndromes (ACS) are among the most critical cardiovascular emergencies, encompassing conditions such as unstable angina, NSTEMI, and STEMI, all linked to reduced blood flow to the heart muscle.

Each condition has distinct clinical and diagnostic characteristics that require rapid identification and appropriate management. Early differentiation between these syndromes is key to improving patient outcomes and limiting severe complications.

VIDAS® HCG, a reliable and high-performance solution for pregnancy diagnosis, supports laboratories in environments wher...
13/05/2026

VIDAS® HCG, a reliable and high-performance solution for pregnancy diagnosis, supports laboratories in environments where speed and accuracy are essential.

✔️ On-demand testing, with no batch constraints
✔️ Fast and reliable results, even in emergency situations
✔️ High precision and excellent correlation with reference methods
✔️ Early detection of pregnancy

An essential solution for fast, confident, and secure clinical decision-making in patient care.

VIDAS® AMH, at the core of the fertility panel, supports laboratories and clinicians with a reliable and high-performanc...
11/05/2026

VIDAS® AMH, at the core of the fertility panel, supports laboratories and clinicians with a reliable and high-performance solution for rapid and relevant assessment of ovarian reserve. Designed to meet everyday demands, it combines operational efficiency with analytical quality.

✔️ On-demand testing, simple and flexible
✔️ Reduced costs and operator time
✔️ Excellent correlation and result reliability
✔️ High precision and reproducibility (CLSI EP05-A3)

It enables laboratories to improve efficiency while optimizing operational costs.

The bioMérieux fertility panel offers a comprehensive hormonal assessment, suitable for both routine testing and emergen...
08/05/2026

The bioMérieux fertility panel offers a comprehensive hormonal assessment, suitable for both routine testing and emergency situations. It enables precise evaluation of hormonal profiles to support informed clinical decision-making.

Reliable, fast, and fully traceable, it integrates seamlessly into the daily workflow of laboratories and fertility centers, while contributing to personalized patient management.

A valuable asset for efficiently managing the fertility journey.

Address

1st Floor, 44 On Grand Central, 1 Bond Street Cnr. Grand Central Boulevard
Midrand
1682

Opening Hours

Monday 08:00 - 16:00
Tuesday 08:00 - 16:00
Wednesday 08:00 - 16:00
Thursday 08:00 - 16:00
Friday 08:00 - 16:00

Telephone

+27112059700

Website

Alerts

Be the first to know and let us send you an email when bioMérieux South Africa posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to bioMérieux South Africa:

Shortcuts

Share

Category